|
|
Denver,
CO—November 19, 2007—The Institute for Corporate Ethics and Governance (ICEG) today announced that
Anthony Boswell has been named by Mayor Richard Daley as Executive Director of Chicago's new Office of Compliance.
"Tony is a
high-energy, goal-driven problem solver who has excellent communication,
analytic and creative skills," Dr. Meaney said. "We are sadden to see him go, but he will no doubt make a key
contribution to the citizens of the City of Chicago by building a world-class ethics and compliance program. It promises to be the first of its kind, a model for other municipalities nation-wide.”
"ICEG enjoyed a growing roster of national and international
clients under Tony's leadership," Meaney added. "I'm very excited for Tony as he embarks on this new and exciting opportunity. Our loss is clearly Chicago's gain."
Boswell is the former
senior vice president of ethics and compliance and US government relations for
the global engineering and construction firm AMEC, where he led the effort to
develop and integrate AMEC’s global ethics and compliance and sustainability
programming.
He joined AMEC from Laidlaw, Inc., a multinational health care and
transportation conglomerate, where he headed the ethics and compliance function for
more than 100,000 employees.
Boswell holds a masters
degree in education from the University of North Carolina at Chapel Hill, and a law degree
from the University of Pennsylvania.
The Institute for Corporate Ethics and Governance helps its domestic
clients implement corporate ethics and compliance programs with a focus on
ethical culture, and its international clients implement global sustainability
programming. The Institute also offers both online and face-to-face training in
a variety of topics including SOX, code of conduct, antitrust, ethical
leadership, corporate social responsibility, FCPA, conflicts of interests and
gifts, e-compliance, environmental awareness, EU competition law, business and
human rights, health and safety, HIPAA, insider trading, sustainable development, sexual harassment,
human subjects research, PhRMA code of conduct, and records management.
|
|